No definition available.
Localized skin eruption due to drugs and medicaments
LOCALIZED_SKIN_ERUPT_DRUGS_MEDICAM
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
401 |
4. Check minimum number of eventsNone |
401 |
5. Include endpointsNone |
401 |
6. Filter based on genotype QC (FinnGen only) |
401 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Localized skin eruption due to drugs and medicaments
based on the number of shared cases.
Similar with more cases:
- Dermatitis due to substances taken internally
- Dermatitis and eczema
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2626 | 1498 | 1115 |
| Only index persons | 2347 | 1368 | 979 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.03 |
| Only index persons | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 51.43 | 54.02 | 47.91 |
| Only index persons | 52.21 | 54.10 | 49.55 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 401 | 257 | 144 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.06 |
| Median age at first event (years) | 54.76 | 52.84 | 58.19 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 347
- Matched controls
- 3469
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L27.1
ICD-10 Finland
Localized skin eruption due to drugs and medicaments
4503599627370496.0
323.0
346
*
H02AB06
ATC
prednisolone; systemic
4.6
38.8
239
1126
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
5.3
23.1
77
178
XQ800
NOMESCO Finland
Prick test
4.8
17.9
63
152
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.5
17.9
99
359
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.4
15.1
57
147
R06AE07
ATC
cetirizine; oral
2.5
14.5
184
1089
D07AC01
ATC
betamethasone; topical
2.5
14.3
149
792
E0000UV
ATC
NA
2.4
13.5
169
982
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
12.9
167
981
XQ820
NOMESCO Finland
Exposure to medicinal substance
72.5
12.7
14
*
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
13.1
12.3
21
17
H02AB02
ATC
dexamethasone; systemic
3.6
11.9
56
176
N02AX02
ATC
tramadol; systemic, rectal
2.2
11.3
162
976
R06AX27
ATC
desloratadine; oral
2.4
11.0
118
616
R06AE09
ATC
levocetirizine; oral
2.8
10.0
68
275
J01AA02
ATC
doxycycline; systemic
2.3
9.7
274
2155
XQ802
NOMESCO Finland
Epicutan test
4.5
9.7
34
82
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
9.7
89
429
A02BC02
ATC
pantoprazole; systemic
2.1
9.5
231
1696
J01MA02
ATC
ciprofloxacin; systemic
2.1
9.5
145
879
J01DB01
ATC
cefalexin; oral
2.4
9.2
296
2441
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
8.9
115
645
A02BC05
ATC
esomeprazole; systemic
2.0
8.8
153
969
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.5
8.8
77
359
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
8.7
48
168
J01FF01
ATC
clindamycin; systemic
2.1
8.1
105
585
UJF32
NOMESCO Finland
Coloscopy
2.1
7.7
101
564
XQ801
NOMESCO Finland
Intracutantest
18.9
7.6
11
6
R50.9
ICD-10 Finland
Fever, unspecified
2.5
7.6
62
277
UDC00
NOMESCO Finland
Ear microscopy
3.3
7.6
38
126
XX3DW
NOMESCO Finland
Time consuming IT work
3.0
7.4
42
152
L03AA13
ATC
pegfilgrastim; parenteral
4.8
7.3
23
50
D07AB02
ATC
hydrocortisone butyrate; topical
2.0
7.2
107
631
J01MA12
ATC
levofloxacin; systemic
2.2
7.1
75
380
A04AA02
ATC
granisetron; systemic, transdermal
3.7
7.1
30
87
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
7.0
140
915
T78.4
ICD-10 Finland
Allergy, unspecified
4.0
6.9
26
68
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
6.9
53
230
J02AC01
ATC
fluconazole; systemic
1.9
6.9
152
1027
J01FA09
ATC
clarithromycin; systemic
1.9
6.6
122
771
L50.9
ICD-10 Finland
Urticaria, unspecified
4.2
6.5
23
57
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.6
6.4
47
198
N03AX16
ATC
pregabalin; oral
2.0
6.4
90
516
K12.00
ICD-10 Finland
Recurrent oral aphthae
9.5
6.3
12
13
ZX120
NOMESCO Finland
Intravenous
2.8
6.3
40
156
D07AD01
ATC
clobetasol; topical
2.2
6.2
63
313
N48.1
ICD-10 Finland
Balanoposthitis
5.9
6.2
16
28
D07AC13
ATC
mometasone; topical
1.9
6.2
106
652
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.9
6.2
13
17
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.0
6.1
23
61
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
6.1
105
645
L50.0
ICD-10 Finland
Allergic urticaria
5.7
6.1
16
29
J01DA01
ATC
[U] cefalexin; systemic
1.8
6.1
216
1678
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
204
1087
2.78
22.45
7.2
6.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
263
1649
2.73
20.15
7.8
5.9
e9/l
0.0
0.0
0.85
242
1439
(3013115) Eosinophils [#/volume] in Blood
268
1703
2.73
19.87
7.9
6.2
e9/l
0.2
0.2
1.77
247
1518
(3022096) Basophils/100 leukocytes in Blood
245
1494
2.64
19.69
8.2
6.0
%
0.7
0.7
0.10
229
1399
(3001604) Monocytes [#/volume] in Blood
261
1646
2.68
19.50
7.8
5.9
e9/l
0.6
0.6
0.41
239
1434
(3019198) Lymphocytes [#/volume] in Blood
265
1692
2.67
19.16
8.1
5.9
e9/l
1.8
1.9
0.85
247
1512
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
231
1397
2.54
18.47
5.6
5.7
mmol/l
1.2
1.2
0.39
212
1276
(3002030) Lymphocytes/100 leukocytes in Blood
252
1591
2.57
18.31
8.4
6.1
%
27.5
28.1
0.43
239
1497
(3013650) Neutrophils [#/volume] in Blood by Automated count
286
1922
2.70
18.17
14.0
9.4
e9/l
4.2
4.0
0.65
262
1694
(3019069) Monocytes/100 leukocytes in Blood
246
1547
2.53
17.85
8.5
6.3
%
8.8
8.4
1.07
231
1461
(3006504) Eosinophils/100 leukocytes in Blood
244
1541
2.49
17.36
8.4
6.0
%
3.1
2.7
1.38
228
1444
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
243
1550
2.44
16.64
6.9
6.6
mmol/l
1.2
1.2
0.12
195
1315
(3023368) Bacteria identified in Blood by Culture
153
803
2.46
16.12
4.8
4.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
243
1573
2.38
15.76
8.0
5.9
%
56.9
57.1
0.09
229
1486
(3032080) INR in Blood by Coagulation assay
204
1228
2.35
15.62
11.0
8.7
inr
1.1
1.2
0.65
71
391
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
333
2537
2.84
14.43
12.4
7.5
u/l
79.9
77.7
0.39
316
2364
(3024561) Albumin [Mass/volume] in Serum or Plasma
209
1302
2.26
14.38
6.4
4.8
g/l
35.4
35.9
0.60
196
1221
(3037522) Nuclear Ab [Titer] in Serum
97
451
2.52
12.91
1.4
1.3
titre
760.0
465.1
0.46
17
99
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
248
1719
2.16
12.34
9.0
6.2
umol/l
10.8
10.6
0.08
235
1630
(40760892) CBC W Ordered Manual Differential panel - Blood
139
788
2.17
11.50
6.2
4.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
316
2483
2.29
10.50
6.2
4.1
mm/h
13.6
11.3
1.74
296
2278
(3007853) Bacteria identified in Skin by Aerobe culture
78
364
2.42
10.12
2.0
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
90
453
2.27
9.80
3.2
2.5
ug/g
112.0
122.9
0.16
66
351
(3037467) Urinalysis macro (dipstick) panel - Urine
296
2297
2.10
9.70
6.1
4.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
91
463
2.25
9.65
1.9
2.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
136
819
2.00
9.22
3.4
3.6
%
92.2
93.2
0.16
129
798
(3012095) Magnesium [Moles/volume] in Serum or Plasma
92
481
2.18
9.08
3.9
3.7
mmol/l
0.8
0.8
0.09
87
455
(3018418) pH of Serum or Plasma
151
947
1.95
9.08
4.2
3.7
ph
7.4
7.4
0.48
42
187
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
151
947
1.95
9.08
2.1
2.1
u/l
207.7
265.3
0.25
141
893
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
160
1028
1.93
8.92
3.1
2.4
u/l
54.5
55.5
0.14
137
949
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
113
648
2.04
8.72
1.9
1.7
pmol/l
447.5
9141203.0
0.50
94
547
(40767503) Oxygen content in Capillary blood by calculation
24
62
4.05
8.55
2.1
2.4
%
17.8
15.7
—
7
25
(3018677) aPTT in Platelet poor plasma by Coagulation assay
89
470
2.15
8.53
1.7
2.1
s
29.3
29.6
0.18
89
456
(3031040) Bacteria [#/volume] in Urine by Automated count
280
2187
1.93
8.25
6.1
4.3
e6/l
116.2
201.6
—
6
40
(3022806) Fractional oxyhemoglobin in Capillary blood
19
42
4.70
8.20
1.3
1.7
%
90.6
89.6
0.26
19
42
(3012501) Base excess in Blood by calculation
25
69
3.80
8.14
3.7
2.6
mmol/l
2.1
2.4
0.17
18
44
(3017181) Myelocytes/100 leukocytes in Blood
61
282
2.37
8.01
6.1
4.4
%
1.2
0.9
0.34
22
87
(3003458) Phosphate [Moles/volume] in Serum or Plasma
75
381
2.19
7.88
4.8
5.6
mmol/l
1.0
1.0
0.37
69
355
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
60
279
2.35
7.77
2.7
2.4
g/l
0.2
0.2
0.36
55
263
(3013826) Glucose [Moles/volume] in Serum or Plasma
249
1894
1.83
7.73
5.7
4.5
mmol/l
6.5
6.6
0.42
240
1756
(3004789) Transferrin [Mass/volume] in Serum or Plasma
85
458
2.09
7.67
2.5
2.1
g/l
2.4
2.4
0.37
80
423
(40768804) Tissue Pathology biopsy report
193
1367
1.79
7.55
2.2
2.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
194
1381
1.78
7.42
2.8
2.3
nmol/l
78.1
76.0
0.42
176
1235
(3026008) Bacteria identified in Urine by Culture
149
981
1.83
7.40
3.4
2.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
95
542
1.99
7.30
1.7
1.7
nmol/l
1321.9
1188.6
0.69
70
404
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
101
589
1.96
7.29
1.4
1.3
iu/ml
16.9
34.3
2.28
37
192
(40768443) Skin Pathology biopsy report
38
146
2.77
7.28
1.3
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
107
639
1.92
7.19
3.6
2.6
mosm/kgh2o
503.4
550.0
1.23
92
543
(3021589) Normoblasts [#/volume] in Blood
208
1521
1.76
7.17
15.0
9.4
e9/l
0.0
0.0
0.29
188
1252
(4035726)
60
290
2.26
7.09
1.6
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
208
1526
1.75
7.05
3.4
2.6
ug/l
121.4
104.2
0.41
191
1409
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
65
328
2.17
6.91
3.7
3.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
158
1076
1.77
6.91
5.6
3.2
mmol/l
2.3
2.4
1.57
141
938
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
375
3340
2.89
6.90
24.5
13.4
mg/l
18.9
21.9
1.41
337
2619
(3021440) Promyelocytes/100 leukocytes in Blood
55
260
2.29
6.84
6.5
4.6
%
0.2
0.1
0.28
19
78
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
44
188
2.51
6.84
3.4
3.5
mmol/l
1.5
1.2
0.22
29
139
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
131
847
1.81
6.80
2.9
3.0
ng/l
1156.8
1097.6
0.09
110
719
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
168
1172
1.75
6.71
4.3
3.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
111
688
1.85
6.58
3.2
2.4
e6/l
5.9
6.1
0.02
97
608
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
77
422
2.02
6.58
2.7
2.2
%
21.6
23.3
0.48
67
362
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
45
198
2.43
6.57
3.5
3.5
kpa
5.0
5.0
0.05
40
185
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
65
3.52
6.51
2.5
3.6
e9/l
4.7
4.6
0.08
22
65
(3035350) Ketones [Presence] in Urine by Test strip
217
1636
1.71
6.47
4.9
3.6
estimate
0.0
0.0
0.00
56
336
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
48
221
2.33
6.34
1.5
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
168
1186
1.72
6.34
4.4
3.5
ng/l
20.4
36.8
2.01
120
788
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
9
5
18.36
6.29
1.0
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
44
196
2.40
6.26
3.4
3.5
ph
7.4
7.4
—
7
19
(3022948) Iron [Moles/volume] in Serum or Plasma
85
492
1.92
6.19
2.7
2.1
umol/l
12.7
13.6
0.51
80
452
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
209
1575
1.68
6.11
4.5
4.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
68
3.37
6.09
3.4
4.0
%
59.4
58.1
0.15
22
68
(3021601) Nitrite [Presence] in Urine by Test strip
216
1643
1.68
6.09
6.4
4.9
estimate
0.0
0.0
0.00
58
339
(3005719) IgG [Mass/volume] in Serum or Plasma
52
253
2.21
6.04
4.1
2.7
g/l
9.5
10.3
0.82
41
234
(3009261) Glucose [Presence] in Urine by Test strip
218
1667
1.67
5.98
4.9
3.6
estimate
0.0
0.0
0.50
57
331
(3025159) Blasts/100 leukocytes in Blood
51
249
2.20
5.87
6.9
4.6
%
0.1
0.0
0.24
14
68
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
83
486
1.89
5.82
2.1
1.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
305
2563
1.79
5.82
5.3
4.0
pmol/l
14.7
14.6
0.23
283
2318
(1616796) Gas panel - Central venous blood
20
60
3.46
5.80
4.1
2.3
—
—
—
0
0
(3013512) EKG study
136
927
1.71
5.71
4.2
3.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
52
259
2.16
5.70
4.2
3.9
mmol/l
1.2
1.2
1.14
45
232
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
174
1267
1.66
5.68
2.1
1.9
pmol/l
97.9
96.5
0.13
97
644
(40768797) Stomach Pathology biopsy report
74
422
1.92
5.61
1.3
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
132
898
1.70
5.56
5.4
3.9
estimate
0.0
0.0
0.00
56
335
(3002179) Metamyelocytes/100 leukocytes in Blood
51
255
2.15
5.53
6.0
4.5
%
1.4
0.4
1.16
11
61
(3030467) Casts [#/volume] in Urine by Automated count
134
917
1.69
5.51
3.8
2.8
e6/l
0.5
0.4
0.10
108
666
(3002582) Erythrocytes [#/volume] in Urine
145
1014
1.67
5.49
4.0
2.9
e6/l
64.2
115.6
0.31
116
765
(3025941) Bacteria identified in Stool by Culture
41
189
2.30
5.41
1.2
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
164
1191
1.64
5.33
4.5
3.4
e6/l
124.2
78.1
0.24
118
827
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
22
5.11
5.29
2.4
2.7
—
—
—
0
0
(4062490)
13
31
4.30
5.13
1.7
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
271
2239
1.65
5.12
3.9
3.2
u/l
48.4
44.9
0.39
252
2105
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
92
580
1.76
5.03
1.4
1.3
u/ml
51.7
11.9
0.39
34
234
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
51
3.44
4.94
1.6
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
56
303
1.99
4.92
5.7
3.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
119
810
1.67
4.91
3.0
2.0
mg/l
3.1
3.1
0.01
99
695
(3022145) Colonoscopy Study observation
67
388
1.87
4.82
1.6
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
112
754
1.67
4.81
1.8
1.8
mg/l
0.9
1.2
0.59
81
591
(21494814) CD8 cells/100 lymphocytes in Specimen
8
7
11.63
4.80
2.1
2.0
—
—
—
0
0
(44813793)
10
20
5.10
4.80
1.2
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
123
849
1.65
4.79
3.0
2.7
umol/l
6506.4
6499.8
0.00
105
730
(3017143) Hepatitis C virus Ab [Presence] in Serum
68
397
1.86
4.77
2.1
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
121
836
1.64
4.68
10.8
6.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
128
900
1.62
4.61
3.8
2.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
173
1309
1.57
4.55
5.3
3.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
59
334
1.90
4.55
3.7
4.4
u/l
219.9
245.1
1.37
54
317
(3021788) Differential panel - Synovial fluid
16
50
3.29
4.38
2.3
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
46
244
2.00
4.28
1.5
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
107
732
1.63
4.26
4.4
3.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
62
2.99
4.22
1.6
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
270
2282
1.56
4.16
4.4
3.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
176
2.15
4.15
1.8
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
104
2.50
4.14
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
117
2.40
4.11
1.5
2.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
37
3.60
4.08
1.1
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
7
10.15
4.02
2.3
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
118
837
1.58
4.02
1.5
1.3
u/ml
1.7
1.3
0.22
35
230
(40760888) Immunoglobulin light chains.free panel - Serum
18
65
2.85
3.90
2.9
4.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
83
2.61
3.86
1.1
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
107
751
1.58
3.79
1.8
1.5
nmol/l
20.9
20.9
0.01
95
644
(3022313) Gas panel - Capillary blood
31
149
2.17
3.74
3.7
3.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
191
2.03
3.72
1.5
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
55
326
1.80
3.67
6.2
7.5
mmol/l
1.9
1.2
0.70
45
269
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
104
2.39
3.67
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
30
3.74
3.66
1.7
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
40
3.33
3.65
1.6
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
340
3072
1.70
3.61
6.4
4.8
mu/l
1.9
1.9
0.20
316
2808
(42529406) Shigella sp [Presence] in Stool by Culture
24
105
2.37
3.60
1.2
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
55
329
1.78
3.56
2.9
2.8
%
1.7
1.7
0.05
47
300
(3028026) IgM [Mass/volume] in Serum or Plasma
39
209
1.96
3.54
2.3
1.7
g/l
0.9
1.3
1.33
34
190
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
55
330
1.77
3.53
2.1
1.9
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
13
41
3.24
3.52
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
265
2270
1.49
3.51
3.6
3.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
107
771
1.53
3.33
2.9
2.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
14
48
2.99
3.33
6.2
3.2
%
1.1
0.9
—
9
40
(3024980) IgG subclass 4 [Mass/volume] in Serum
14
48
2.99
3.33
2.1
2.0
g/l
0.4
0.9
—
9
41
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
90
2.41
3.30
2.1
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
90
2.41
3.30
1.5
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
145
1115
1.47
3.29
3.4
3.3
u/l
29.0
31.8
0.68
135
1067
(3000991) Gas panel - Venous blood
41
230
1.87
3.27
5.0
8.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
53
322
1.74
3.26
6.9
4.0
ug/l
12.4
41.0
0.58
44
266
(3019225) pH of Specimen
49
291
1.78
3.26
4.7
4.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
44
253
1.83
3.25
3.0
4.3
mmol/l
2.0
1.9
0.06
34
197
(3045424) Erythrocytes [Presence] in Urine
14
49
2.92
3.22
1.3
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
33
3.40
3.21
1.2
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
36
195
1.93
3.19
3.1
2.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
48
286
1.77
3.16
1.2
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
51
310
1.74
3.14
2.0
2.2
u/l
30.0
31.1
0.13
43
255
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
86
2.40
3.13
1.5
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
53
328
1.71
3.06
2.0
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
60
386
1.65
3.00
1.2
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
134
1035
1.44
2.91
2.8
2.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
158
1.97
2.89
5.9
9.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
40
233
1.80
2.85
2.1
3.1
e9/l
72.5
71.3
0.07
29
184
(3019174) dRVVT (LA screen)
5
6
8.42
2.75
1.4
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
6
8.42
2.75
1.4
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
376
3551
1.94
2.71
17.5
10.2
u/l
24.8
25.7
0.63
367
3423
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
6
10
6.07
2.70
1.2
1.0
umol/l
5.2
6.3
—
6
10
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
342
3151
1.58
2.70
21.5
12.2
ml/min/173m2
83.9
83.9
0.00
300
2564
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
79
558
1.52
2.67
1.8
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
34
193
1.83
2.64
5.8
4.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
21
100
2.16
2.64
1.4
2.0
mg/l
8.6
11.1
0.89
21
94
(4010399)
41
247
1.74
2.62
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
87
2.24
2.61
1.8
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
20
4.06
2.58
6.6
3.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
328
3004
1.50
2.56
6.4
5.6
mmol/mol
39.3
39.5
0.14
296
2803
(40761511) CBC panel - Blood by Automated count
371
3499
1.81
2.54
21.3
12.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
28
151
1.92
2.54
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
37
219
1.76
2.52
3.4
2.1
e9/l
3.7
4.0
0.72
27
175
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
152
1.91
2.50
1.1
1.4
iu/l
19.1
25.2
0.42
23
131
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
95
706
1.45
2.49
1.8
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
19
89
2.19
2.49
3.9
4.0
mg/l
251.5
124.4
0.22
13
74
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
19
89
2.19
2.49
3.9
4.0
mg/l
20.2
29.2
0.96
14
73
(3041096) Erythrocytes [Presence] in Urine by Automated
124
968
1.41
2.48
4.6
3.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
22
110
2.06
2.46
1.9
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
83
2.22
2.45
2.2
2.6
u/ml
0.5
0.3
0.53
12
46
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
70
2.34
2.44
1.4
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
16
70
2.34
2.44
2.9
2.8
kpa
9.3
8.5
1.38
16
63
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
12
5.06
2.41
1.5
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
42
262
1.67
2.38
1.5
1.3
iu/ml
116.4
159.3
0.20
15
108
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
52
2.55
2.38
1.3
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
91
2.14
2.37
1.2
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
98
2.10
2.36
3.4
3.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
75
538
1.48
2.35
3.3
2.5
e6/l
1.1
0.9
0.20
43
288
(3009542) Hematocrit [Volume Fraction] of Blood
332
3065
1.48
2.32
20.8
14.1
%
39.5
40.0
0.58
231
2304
(3021901) Oxygen saturation in Capillary blood
12
47
2.60
2.29
3.1
2.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
18
3.94
2.26
1.6
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
98
746
1.42
2.25
1.9
1.4
g/l
2.2
2.4
0.52
55
453
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
54
2.45
2.22
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
54
2.45
2.22
1.1
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
9
5.61
2.22
10.0
3.6
%
49.9
47.9
—
5
9
(3044941) Cell count panel - Synovial fluid
11
42
2.66
2.20
2.0
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
19
3.73
2.16
1.7
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
95
2.05
2.14
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
25
3.24
2.10
1.8
1.8
—
—
—
0
0
(3000492) Spirometry study
46
304
1.58
2.10
1.6
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
110
1.96
2.10
4.3
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
31
2.95
2.08
2.1
2.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
37
233
1.65
2.05
3.1
3.6
ng/l
72.0
71.4
0.02
30
209
(3042631) Mycobacterium sp identified in Specimen
11
44
2.54
2.03
3.1
3.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
38
2.67
2.02
2.0
1.3
—
—
—
0
0
(4146454)
9
32
2.85
2.01
1.7
2.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
69
503
1.45
2.00
3.5
2.7
e6/l
4.4
2.6
0.79
38
256
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
77
2.12
1.99
1.3
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
21
3.37
1.97
1.6
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
59
421
1.47
1.91
1.7
1.8
%
1.5
1.5
0.01
48
369
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
40
2.54
1.85
1.3
1.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
17
3.57
1.84
1.7
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
18
94
1.96
1.83
4.7
6.6
mmol/l
1.3
1.2
0.30
18
80
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
12
4.20
1.83
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
12
4.20
1.83
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
13
60
2.21
1.79
1.8
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
25
147
1.75
1.78
3.6
2.5
u/l
1106.8
3751.5
—
9
59
(3052851) Hemolysis interference index of Serum or Plasma
18
95
1.94
1.78
1.8
2.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
155
1.72
1.77
2.0
1.6
—
—
—
0
0
(4268621)
10
41
2.48
1.76
2.1
2.1
—
—
—
0
0
(3020891) Body temperature
20
110
1.86
1.76
7.0
3.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
77
587
1.39
1.74
3.5
3.5
ng/l
363.7
295.6
0.08
56
438
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
13
3.88
1.72
1.0
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
13
3.88
1.72
2.4
2.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
13
3.88
1.72
1.0
1.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
13
3.88
1.72
1.0
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
42
2.42
1.69
1.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
42
2.42
1.69
1.7
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
113
922
1.31
1.64
4.4
4.2
mg/mmol
8.4
9.0
0.08
67
574
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
341
3217
1.40
1.62
5.4
4.4
mmol/l
5.9
5.9
0.15
313
2957
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
14
3.60
1.62
2.0
2.1
u/ml
762.8
871.9
—
5
14
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
121
1.78
1.61
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
111
911
1.30
1.54
1.6
1.7
mmol/l
1.4
1.3
0.15
87
767
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
51
2.19
1.52
1.8
2.0
u/ml
4.2
83.7
0.48
11
46
(3037121) Protein [Mass/volume] in Urine
20
116
1.76
1.51
4.7
3.7
g/l
0.3
0.2
—
8
50
(3045414) Leukocytes [Presence] in Urine
21
124
1.73
1.50
1.7
1.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
65
2.03
1.50
2.1
6.9
—
413.8
—
0
12
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
52
2.15
1.45
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
73
1.95
1.45
1.1
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
23
359
0.62
1.44
1.6
1.4
—
—
—
0
0
(4024509)
6
22
2.75
1.44
4.2
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
39
2.34
1.44
1.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
111
1.75
1.41
1.5
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
46
2.20
1.41
1.7
1.7
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
7
29
2.44
1.40
2.9
2.1
e9/l
0.2
0.2
—
7
24
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
53
2.11
1.39
1.6
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
23
2.63
1.37
1.2
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
47
2.16
1.34
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
47
2.16
1.34
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
106
880
1.28
1.34
3.5
3.3
mg/l
683.9
52.3
0.49
64
562
(3009508) Creatinine [Moles/volume] in Urine
116
974
1.27
1.33
3.6
3.2
mmol/l
7.1
7.8
0.99
90
815
(3010726) Horse dander IgE Ab [Units/volume] in Serum
9
43
2.12
1.31
1.0
1.0
—
2.7
—
0
7
(46235355) HIV 1 and 2 tests - Meaningful Use set
85
690
1.29
1.27
2.3
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
36
254
1.46
1.27
4.0
2.5
ml/min/173m2
58.7
67.1
0.62
15
103
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
76
608
1.31
1.27
1.8
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
21
131
1.64
1.26
1.2
1.6
—
10.1
—
0
5
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
25
2.42
1.25
1.3
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
6
25
2.42
1.25
1.3
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
60
465
1.34
1.24
2.6
2.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
124
1.65
1.23
2.1
2.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
64
1.90
1.19
1.8
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
6
26
2.33
1.19
1.0
1.1
—
5.2
—
0
9
(44790049)
8
38
2.13
1.19
1.4
1.6
—
—
—
0
0
(44806118)
8
38
2.13
1.19
1.4
1.6
—
—
—
0
0
(44790047)
8
38
2.13
1.19
1.4
1.6
—
—
—
0
0
(44790048)
8
38
2.13
1.19
1.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
72
1.83
1.16
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
39
2.07
1.16
1.4
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
56
435
1.33
1.15
1.3
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
20
2.52
1.15
5.0
2.9
mu/l
45.6
11.7
—
5
20
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
17
103
1.68
1.14
1.2
3.0
%
100.8
91.9
0.84
12
98
(3002523) Influenza virus A Ag [Presence] in Specimen
12
65
1.87
1.14
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
65
1.87
1.14
1.1
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
7
30
2.36
1.13
2.7
2.1
e6/l
739.7
478.9
—
7
24
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
30
2.36
1.13
1.7
2.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
40
2.02
1.12
2.0
3.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
115
983
1.24
1.12
1.6
1.5
—
—
—
0
0
(4306422)
10
51
1.99
1.12
1.4
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
28
194
1.48
1.10
1.1
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
51
394
1.34
1.09
5.7
4.4
%
32.3
32.0
0.06
41
262
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
161
1.52
1.09
2.1
2.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
54
421
1.33
1.09
2.6
2.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
59
1.89
1.08
1.6
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
35
255
1.41
1.07
5.3
3.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
52
1.95
1.07
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
33
2.14
1.06
1.4
2.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
33
2.14
1.06
1.1
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
90
1.69
1.05
1.1
1.3
ug/g
395.0
298.6
—
7
48
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
46
1.98
1.04
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
18
115
1.59
1.01
1.9
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
48
373
1.33
1.00
1.6
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
76
1.73
1.00
1.2
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
23
2.19
0.98
1.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
54
1.87
0.97
1.0
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
48
376
1.31
0.95
31.0
19.0
inr
1.1
1.2
—
5
53
(3036489) Thrombin time
18
118
1.55
0.92
1.4
2.9
s
20.8
22.0
0.49
13
105
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
118
1.55
0.92
1.6
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
35
263
1.36
0.91
2.8
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
1.2
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
120
1.52
0.87
2.0
2.5
—
—
—
0
0
(1002224) Polysomnography panel
21
146
1.46
0.84
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
81
1.63
0.82
1.4
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
13
81
1.63
0.82
1.1
1.2
—
35.9
—
0
9
(3023410) Appearance of Cerebral spinal fluid
6
32
1.89
0.82
2.5
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
100
871
1.20
0.81
5.8
4.8
ug/l
2.3
2.5
0.19
83
779
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
33
1.83
0.79
1.5
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
33
1.83
0.79
1.5
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
33
1.83
0.79
1.5
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
25
0.00
0.79
0.0
1.7
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
5.2
—
0
7
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
327
3148
1.21
0.76
4.5
3.9
mmol/l
1.3
1.3
0.54
298
2911
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
46
372
1.27
0.75
11.6
6.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
339
3278
1.22
0.73
4.9
4.3
mmol/l
4.7
4.7
0.13
312
3050
(40768441) Liver Pathology biopsy report
5
25
2.01
0.73
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
56
1.62
0.73
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
40
1.76
0.71
1.0
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
101
1.50
0.71
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
28
213
1.34
0.70
2.9
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
84
730
1.19
0.70
5.8
3.8
kg/l
1.0
1.0
—
7
100
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
41
1.72
0.70
1.1
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
41
1.72
0.70
1.1
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
41
1.72
0.70
1.1
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
41
1.72
0.70
1.1
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
61
1.66
0.69
4.1
2.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
214
1.33
0.69
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
42
1.68
0.68
1.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
42
1.68
0.68
1.1
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
27
1.86
0.68
1.0
1.0
—
0.0
—
0
5
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
28
1.80
0.66
1.0
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
11
70
1.59
0.66
6.5
6.4
mmol/l
103.1
105.6
0.95
11
60
(3039000) Anion gap in Blood
11
70
1.59
0.66
6.5
6.4
mmol/l
12.1
10.6
0.47
11
60
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
29
1.73
0.64
1.2
2.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
50
1.61
0.61
3.8
1.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
336
3262
1.19
0.59
5.0
4.3
mmol/l
1.5
1.5
0.30
307
3021
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
53
1.52
0.58
1.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
10.4
—
0.6
—
0
23
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
35
1.72
0.58
1.0
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
55
1.46
0.56
1.9
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
6
37
1.63
0.55
1.2
1.1
g/l
1.7
1.4
—
6
32
(3019832) Treponema pallidum Ab [Presence] in Serum
46
388
1.21
0.54
2.4
1.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
18
134
1.36
0.54
3.3
3.6
%
45.0
48.3
0.23
18
134
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
18
134
1.36
0.54
5.7
5.0
%
3.4
1.5
0.91
18
123
(3011288) Drugs identified in Urine by Screen method
13
91
1.44
0.53
2.7
2.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
97
0.61
0.52
1.7
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
135
0.66
0.52
1.6
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
40
1.51
0.52
2.0
2.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
342
3337
1.17
0.49
5.4
4.8
mmol/l
2.7
2.8
0.53
312
3082
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
109
0.64
0.49
1.7
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
109
0.64
0.49
1.7
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
109
0.64
0.49
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
109
0.64
0.49
1.6
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
46
1.53
0.48
1.0
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
23
182
1.28
0.47
3.7
2.6
e6/l
0.2
0.1
0.23
23
173
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
120
0.66
0.46
1.8
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
50
1.41
0.45
1.7
1.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
17
130
1.32
0.44
6.0
5.1
%
1.0
0.9
0.39
17
120
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
31
1.62
0.43
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
94
0.63
0.42
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
94
0.63
0.42
1.7
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
206
0.77
0.42
1.7
1.5
—
—
—
0
0
(4281824)
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
123
1.31
0.41
1.3
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
34
1.48
0.40
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
88
1.37
0.40
1.3
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
117
1.29
0.35
2.6
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
89
0.67
0.33
1.7
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
134
1264
1.09
0.33
3.2
2.8
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
6
47
1.28
0.32
1.0
1.4
mmol/l
6.8
7.3
—
6
32
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
28
322
0.86
0.28
2.2
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
65
1.24
0.27
1.7
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
86
1.29
0.26
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
84
0.71
0.24
6.5
4.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
39
1.29
0.23
1.4
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
18
210
0.85
0.22
2.3
2.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
17
144
1.19
0.22
3.1
2.7
%
1.3
1.2
0.40
17
144
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
144
0.83
0.20
2.7
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
49
1.23
0.20
1.3
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
227
0.87
0.18
1.5
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
153
0.84
0.18
4.8
3.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
148
1.16
0.17
1.5
1.5
mg/l
2.2
3.1
—
10
104
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
120
1.17
0.16
1.2
1.5
miu/ml
177.0
265.6
—
5
64
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
70
1.15
0.16
2.4
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
71
1.13
0.16
1.0
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
80
0.75
0.15
1.0
1.2
—
—
—
0
0
(4094501)
10
83
1.21
0.15
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
181
0.88
0.14
1.8
1.8
—
—
—
0
0
(4034850)
9
108
0.83
0.13
16.7
9.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
393
0.94
0.11
1.8
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
74
715
1.04
0.09
4.6
4.4
%
24.5
20.7
1.44
38
332
(3038515) Glucose [Moles/volume] in Venous blood
5
64
0.78
0.08
3.6
3.3
mmol/l
6.4
7.3
—
5
64
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
51
516
0.99
0.00
3.4
3.0
ug/l
0.8
0.7
0.05
36
332
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
119
1.01
0.00
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
123
0.97
0.00
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
143
0.98
0.00
2.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
145
0.96
0.00
2.4
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
144
0.97
0.00
2.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
136
1.03
0.00
2.4
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
67
0.89
0.00
2.2
2.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
73
0.96
0.00
1.4
1.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
59
1.02
0.00
3.5
3.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
8.8
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
38.8
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
91
0.99
0.00
1.3
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
2.0
—
10950.8
—
0
5
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
22.1
—
0
7
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
98
0.92
0.00
1.3
1.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
8.8
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
18.1
—
0
6
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
53.5
—
0
7
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.3
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
-0.00
0.0
1.1
—
3.4
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint LOCALIZED_SKIN_ERUPT_DRUGS_MEDICAM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| LOCALIZED_SKIN_ERUPT_DRUGS_MEDICAM | 1.557 [1.26, 1.93] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.626 |
During the follow-up period (1.1.1998 — 31.12.2019), 246 out of 1248 females with LOCALIZED_SKIN_ERUPT_DRUGS_MEDICAM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| LOCALIZED_SKIN_ERUPT_DRUGS_MEDICAM | 1.561 [1.26, 1.93] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.027 |
During the follow-up period (1.1.1998 — 31.12.2019), 181 out of 969 males with LOCALIZED_SKIN_ERUPT_DRUGS_MEDICAM died.
Mortality risk
Mortality risk for people of age
years, who have LOCALIZED_SKIN_ERUPT_DRUGS_MEDICAM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.143% | 0.415% |
| 5 | 1.089% | 2.227% |
| 10 | 2.717% | 5.267% |
| 15 | 4.883% | 9.734% |
| 20 | 8.541% | 15.853% |
Relationships between endpoints
↥Index endpoint: LOCALIZED_SKIN_ERUPT_DRUGS_MEDICAM – Localized skin eruption due to drugs and medicaments
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data